Charide, Rana
Stallwood, Lisa
Munan, Matthew
Sayfi, Shahab
Hartling, Lisa
Butcher, Nancy J.
Offringa, Martin
Elliott, Sarah
Richards, Dawn P.
Mathew, Joseph L.
Akl, Elie A.
Kredo, Tamara
Mbuagbaw, Lawrence
Motillal, Ashley
Baba, Ami
Prebeg, Matthew
Relihan, Jacqueline
Scott, Shannon D.
Suvada, Jozef
Falavigna, Maicon
Klugar, Miloslav
Lotfi, Tamara
Stevens, Adrienne
Pottie, Kevin
Schünemann, Holger J. http://orcid.org/0000-0003-3211-8479
Funding for this research was provided by:
Canadian Institutes of Health Research (GA3-177732)
Article History
Received: 8 November 2022
Accepted: 3 January 2023
First Online: 14 January 2023
Declarations
:
: After review, the Hamilton Integrated Research Ethics Board (HiREB) has approved this study. The University of Alberta Research Ethics Board has approved the parent portion of this study. The results of this study will be published in peer-reviewed journals: one for each population and one presenting the pooled results. We also aim to present the results in national and international conferences and distribute them through other media. The authors of this protocol follow the ICMJE authorship criteria.The study survey includes the consent form that describes the study purpose, confidentiality, potential risks, and voluntary participation (Supplementary Material InternalRef removed). Consent will be obtained from all participants in the study by overt action (i.e., by completing the survey). As for the interview, the consent form will be shared via email (Supplementary Material InternalRef removed), and the research coordinator conducting the interview will obtain verbal consent from the participant for participating in the interview and for the interview to be audio-recorded.
: Not applicable.
: NJB receives research funding from the Canadian Institutes of Health Research, CHILD-BRIGHT, and the Cundill Centre for Child and Youth Depression. NJB also declares consulting fees from Nobias Therapeutics, Inc.RC, LS, MM, SS, LH, MO, SE, DPR, JLM, EAA, TK, AM, AB, MP, JR, SDS, JS, MF, MK, TL, AS, KP, and HJS have no competing interests.